Navigation Links
Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
Date:6/16/2008

ent organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, medical device, and medical diagnostic industries for over 20 years. With a staff of more than 300 employees located in the United States, Europe, Canada, Israel, and South Africa, Cato Research's services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval.

Safe Harbor Statement

Statements made in this release that are not historical in nature constitute forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements can be identified by the use of words such as "expects," plans" "will," "may," "anticipates," believes," "should," intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, and technological changes. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-KSB filed with the SEC on March 26, 2008. Such documents may be read free of charge on the SEC's web site at http://www.sec.gov. All forward-looking statements included in this release are made as of the date of this press release, and the Company assumes no obl
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
2. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
3. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
4. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
5. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
6. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
7. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
8. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
9. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
10. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
11. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 Vanda Pharmaceuticals Inc. ... data today at ENDO 2013, the Endocrine Society,s ... can entrain (synchronize) both melatonin and cortisol rhythms. ... the master body clock and address the circadian ... The SET (Safety and Efficacy of Tasimelteon) and ...
(Date:6/17/2013)... SAN DIEGO , June 17, 2013 BioMed ... that its board of directors has declared a second quarter ... dividend is equivalent to an annualized dividend of $0.94 per ... payable on July 15, 2013 to stockholders of record at ... About BioMed Realty Trust BioMed Realty delivers ...
(Date:6/17/2013)... , June 17, 2013  A little known drug ... under scrutiny by the U.S. Supreme Court – and a ... issue could not have come at a better time for ... result from the Rx industry tactic are all too apparent ... of 50+ New Yorkers, state residents are in a near ...
Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 3
... a leading Clinical Research Organization, will exhibit its comprehensive ... for Medical Oncology,s 35th annual congress to be held ... from Medical Affairs, Operations and other departments will be ... successful execution of oncology and hematology trials. ...
... 8 Concentric Medical, Inc. today announced the ... utilizing Stentriever™ technology for clot retrieval in ischemic ... offering in a portfolio of products from Concentric ... acute ischemic stroke. The Trevo,s stent-like design leverages ...
Cached Medicine Technology:PRA International to Exhibit at European Oncology Congress 2Concentric Medical Announces Commercial Launch of Trevo™ in Europe 2Concentric Medical Announces Commercial Launch of Trevo™ in Europe 3
(Date:6/18/2013)... Internationally acclaimed plastic surgeon, Dr. John ... his unique approach to breast augmentation. Dr. Tebbetts’ ... method and highlights the results of Dr. Tebbetts’ ... Tebbetts compares his breast augmentation method to other ... does not necessitate the use drains, bandages, narcotic ...
(Date:6/18/2013)... 2013 More than 1.1 million people in ... according to the Centers for Disease Control and Prevention (CDC). ... In support of National HIV Testing Day on June 27, ... (SSDI) representation, the CDC and other organizations are raising ... CDC reports about 50,000 new HIV infections each year. Along ...
(Date:6/18/2013)... Atlanta (PRWEB) June 18, 2013 ... Cypress Care, ScripNet and Procura Management, today announced ... of chief sales officer. In this position, Leonardo ... support of the company’s strategic growth initiatives. , ... his leadership and expertise, Leonardo brings more than ...
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 New York ... Center to its “Best Doctors” list, up from 129 ... York City. The new issue also lists 52 additional doctors ... continues on a strategic growth trajectory. The “Best Doctors” issue, ... in the June 24 print issue and is available online ...
(Date:6/18/2013)... Hospitals Case Medical Center enrolled their first patients in ... a novel, less-invasive procedure to help clear blockages in ... more than 300,000 people in the United States are ... If left untreated, these blockages can slow or even ... disabling stroke, also known as a "brain attack." ...
Breaking Medicine News(10 mins):Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
... indicator of an industry's health, then the turnout for this ... fair, confirms the sector is doing nicely, if not booming. ... show, a two-yearly event in Bordeaux, a three percent rise ... by the London-based International Wine and Spirit Record (IWSR) showed ...
... with a partner in Harley Street - a street ... frequented by celebrities - and is introducing Ayurveda ... tie-up based on her franchise system with the LXiR ... on Harley Street is indicative of the increasing worldwide ...
... Antarctic ice sheet to break up, even though the air ... for at least a century, according to a new study ... Zealand. ,As part of their study, the team led ... measuring how high the ice had deposited boulders in Antarctica's ...
... problems in the Health Service, which no Government seems ... of Totnes, the Ven. John Rawlings in his sermon ... eve of its Annual Conference. ,In his sermon ... says: We live in exciting times. But, sadly, the ...
... annual HealthGrades Womens Health Outcomes in U.S. Hospitals ... nation's best- performing hospitals have a 39 percent ... women at the nation's poorest-performing hospitals. ... largest quality gaps between the best-performing and poorest-performing ...
... hired outgoing Prime Minister Tony Blair's wife, Cherie, to ... described Tony Blair as an 'a***hole' on peak-time radio ... boss, resorted to the use of unparliamentary language after ... his club should be exempted from new cigarette laws. ...
Cached Medicine News:Health News:World Wine Sales Brisk, but French Producers Hungover 2Health News:World Wine Sales Brisk, but French Producers Hungover 3Health News:Shahnaz Hussain Takes Ayurveda to London's Harley Street 2Health News:Best-performing Hospitals Has Reduced Cardiovascular Mortality 2
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 16 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm....
Medicine Products: